Dir
Soren Bo Christiansen, MD, is an independent director and board member at Sharps Technology Inc. (NASDAQ: STSS), where he joined the board in April 2018, served as CEO from April 2019 to September 2021, and held various chairman roles including Chairman from December 2018, Co-Chairman from 2021 to July 2023, Chairman from August 2023 until June 30, 2025, when he transitioned following Paul Danner's appointment as Executive Chairman.[[1]](https://fintool.com/app/research/companies/STSS/people/soren-bo-christiansen)[[4]](https://www.sharpstechnology.com/investors/board-of-directors) Currently, at age 69, he serves on the Audit Committee (member), Compensation Committee (member), and chairs the Nominating & Governance Committee, contributing his expertise in pharmaceuticals, vaccines, and governance.[[1]](https://fintool.com/app/research/companies/STSS/people/soren-bo-christiansen)[[7]](https://www.sec.gov/Archives/edgar/data/1737995/000164117225017827/form8-k.htm)
Dr. Christiansen holds a medical degree from the University of Copenhagen and boasts a 30-year career at Merck & Co., Inc., where he advanced to senior leadership positions such as Sr. VP of Merck Vaccines (Global Commercial), President of Eastern Europe, Middle East & Africa, and President of Europe, Middle East, Africa & Canada.[[1]](https://fintool.com/app/research/companies/STSS/people/soren-bo-christiansen) Recently, as a director, he acquired 80,000 stock options at $6.41 each totaling $512,800 under the 2025 Equity Incentive Plan (vesting May 22, 2026), and separately 100,000 options valued at $28.5k, reflecting ongoing commitment to the company; his beneficial ownership includes approximately 20,000-26,000 shares plus options as of late 2025.[[1]](https://fintool.com/app/research/companies/STSS/people/soren-bo-christiansen)[[2]](https://www.tradingview.com/news/tradingview:a46d2d4ab4d72:0-sharps-technology-executives-and-directors-acquire-options-and-shares/)[[3]](https://www.gurufocus.com/insider/177127/soren-bo-christiansen)[[5]](https://www.investing.com/news/company-news/sharps-technology-director-acquires-285k-in-stock-options-93CH-3407701)
View full insider profile →
